SeaStar Medical Holding (ICU) Share-based Compensation (2022 - 2026)
SeaStar Medical Holding's (ICU) quarterly Share-based Compensation came in at $91000.0 in Q1 2026, down 45.51% YoY from $167000.0 in Q1 2025, and up 135.55% on a QoQ basis from -$256000.0 in Q4 2025.
SeaStar Medical Holding (ICU) Share-based Compensation (2022 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 5 years of Share-based Compensation data on file, last reported at $91000.0 in Q1 2026.
- Quarterly Share-based Compensation fell 45.51% year-over-year to $91000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $222000.0 (down 64.19% YoY) and the FY2025 annual result came in at $298000.0, down 66.4% from the prior year.
- Share-based Compensation improved to $91000.0 in Q1 2026, from -$256000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $605000.0 in Q4 2022 to a low of -$1.1 million in Q4 2023.
- A 5-year average of $178764.7 and a median of $212000.0 in 2024 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 12525.0% in 2023, down 280.5% in 2023.
- Tracing ICU's Share-based Compensation over 5 years: stood at $605000.0 in 2022, then plunged by 280.5% to -$1.1 million in 2023, then jumped by 119.41% to $212000.0 in 2024, then sank by 220.75% to -$256000.0 in 2025, then jumped by 135.55% to $91000.0 in 2026.
- The last three Share-based Compensation figures came in at $91000.0 (Q1 2026), -$256000.0 (Q4 2025), and $290000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 86.63 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | 28.05 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 41.25 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | - |
| 10 | SeaStar Medical Holding | 14.07 Mn | 7.07 Mn | 561,000.00 | -141,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -141,000.00 |
| Jun 30, 2026 | -141,000.00 |
| Mar 31, 2026 | 91,000.00 |
| Mar 31, 2026 | 91,000.00 |
| Dec 31, 2025 | -256,000.00 |
| Dec 31, 2025 | -256,000.00 |
| Sep 30, 2025 | 290,000.00 |
| Sep 30, 2025 | 290,000.00 |
| Jun 30, 2025 | 97,000.00 |
| Jun 30, 2025 | 97,000.00 |
| Mar 31, 2025 | 167,000.00 |
| Mar 31, 2025 | 167,000.00 |
| Dec 31, 2024 | 212,000.00 |
| Dec 31, 2024 | 212,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 41,000.00 |
| Jun 30, 2024 | 41,000.00 |
| Mar 31, 2024 | 434,000.00 |
| Mar 31, 2024 | 434,000.00 |